Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „occurring“
Suchtreffer
Begriffe & Kennungen
Miglustat Gen.Orph · 4.8 · Adverse reactions from clinical studies and spontaneous reporting, occurring in > 1% of patients, are listed i
Eintrag öffnenModigraf · 4.8 · The most commonly reported adverse reactions (occurring in > 10% of patients) are tremor, renal impairment, hy
Eintrag öffnenMozobil · 4.8 · Table 1. Adverse reactions occurring more frequently with Mozobil than placebo and considered related to Mozob
Eintrag öffnenNaglazyme · 4.8 · Infusion reactions, defined as adverse reactions occurring during Naglazyme infusions or until the end of the
Eintrag öffnenNexavar · 4.8 · CTCAE Grade 3 or 4 laboratory abnormalities occurring in ≥ 5 % of sorafenib treated patients included lymphope
Eintrag öffnenNulojix · 4.8 · 11 Table 3: Malignancies occurring by treatment group (%) Up to Year 1 Up to Year 3*,** Belatacept Belatacept
Eintrag öffnenNulojix · 4.8 · In newly transplanted patient studies, acute infusion-related reactions (reactions occurring within one hour o
Eintrag öffnenNulojix · 4.8 · Infections In newly transplanted patient trials, Year 1 and Year 3 frequencies of infections occurring by trea
Eintrag öffnenNulojix · 4.8 · Table 4: Infections occurring by treatment group in newly transplanted patient trials (%) Up to Year 1 Up to Y
Eintrag öffnenOdomzo · 4.8 · The most common adverse drug reactions occurring in ≥10% of patients treated with Odomzo 200 mg were muscle sp
Eintrag öffnenOdomzo · 4.8 · The most common grade 3/4 adverse drug reactions occurring in ≥2% of patients treated with Odomzo 200 mg were
Eintrag öffnenOdomzo · 4.8 · The most commonly reported grade 3/4 laboratory abnormalities with an incidence of ≥ 5% occurring in patients
Eintrag öffnenOnpattro · 4.8 · The most frequently occurring adverse reactions reported in Onpattro-treated patients were peripheral oedema (
Eintrag öffnenOrencia · 4.8 · Infusion-related reactions Acute infusion-related events (adverse reactions occurring within 1 hour of the sta
Eintrag öffnenPluvicto · 4.8 · 8 Table 2 Adverse reactions occurring at a higher incidence in patients who received Pluvicto plus BSoC compar
Eintrag öffnenPradaxa · 4.8 · The most commonly reported events are bleedings occurring in approximately 14 % of patients treated short-term
Eintrag öffnenPradaxa · 4.8 · The most commonly reported events are bleedings occurring in approximately 14 % of patients; the frequency of
Eintrag öffnenPradaxa · 4.8 · The most commonly reported events are bleedings occurring in approximately 16.6 % in patients with atrial fibr
Eintrag öffnenPrezista · 4.8 · Rash In clinical trials, rash was mostly mild to moderate, often occurring within the first four weeks of trea
Eintrag öffnenPrezista · 4.8 · Rash In clinical trials, rash was mostly mild to moderate, often occurring within the first four weeks of trea
Eintrag öffnen